Menu
Close
About Us
Company Overview
Leadership
Board of Directors
Business Advisors
Scientific Advisory Board
Corporate Governance
Our Focus
COVID-19 and CVD
Acute Myocarditis
Heart Failure
R&D Partners
Our Science
Resources
Products
Investors
Events & Presentations
Press Releases
Analyst Coverage
Stock Information
Filings & Financials
AGM
Contact Us
News
Cardiol Therapeutics’ Cortalex™ CBD Now Available Exclusively Online at Medical Cannabis by Shoppers Inc.
October 20, 2020
Cardiol Therapeutics Receives FDA Approval for Investigational New Drug (IND) Application for Phase II/III COVID-19 Trial
September 25, 2020
Cardiol Therapeutics to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference
September 15, 2020
Cardiol Therapeutics Initiates Health Canada Approved Phase 1 Clinical Study of CardiolRx™
August 26, 2020
Cardiol Therapeutics Appoints CNBC Market Analyst Steven Grasso as Business Advisor
June 29, 2020
David Elsley Files Early Warning Report for Cardiol Therapeutics
June 25, 2020
Cardiol Therapeutics Closes $17.25 Million Bought Deal Offering, Including Full Exercise of the Over-Allotment Option
June 04, 2020
Cardiol Therapeutics Reports 2020 AGM Results
June 02, 2020
Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 1st at 4:30 p.m. EDT
May 29, 2020
Cardiol Therapeutics Announces Increase to Previously Announced Bought Deal Public Offering
May 14, 2020
Page 1 of 6
1
2
3
4
5
...
»
Last »
